000 | 01449 a2200469 4500 | ||
---|---|---|---|
005 | 20250517072144.0 | ||
264 | 0 | _c20190510 | |
008 | 201905s 0 0 eng d | ||
022 | _a1512-0112 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSaker, Z | |
245 | 0 | 0 |
_aIMPORTANCE OF APOPTOSIS MARKERS (MDM2, BCL-2 AND Bax) IN CONVENTIONAL RENAL CELL CARCINOMA. _h[electronic resource] |
260 |
_bGeorgian medical news _cDec 2015 |
||
300 |
_a27-33 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aApoptosis _xgenetics |
650 | 0 | 4 |
_aCarcinoma, Renal Cell _xgenetics |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKidney _xmetabolism |
650 | 0 | 4 |
_aKidney Neoplasms _xgenetics |
650 | 0 | 4 | _aLymphatic Metastasis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aNephrectomy _xmethods |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xgenetics |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-mdm2 _xgenetics |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 | _aTumor Burden |
650 | 0 | 4 |
_abcl-2-Associated X Protein _xgenetics |
700 | 1 | _aTsintsadze, O | |
700 | 1 | _aJiqia, I | |
700 | 1 | _aManagadze, L | |
700 | 1 | _aChkhotua, A | |
773 | 0 |
_tGeorgian medical news _gno. 249 _gp. 27-33 |
|
999 |
_c25589531 _d25589531 |